751 related articles for article (PubMed ID: 27354785)
1. Impact of mild exacerbation on COPD symptoms in a Japanese cohort.
Sato M; Chubachi S; Sasaki M; Haraguchi M; Kameyama N; Tsutsumi A; Takahashi S; Nakamura H; Asano K; Betsuyaku T
Int J Chron Obstruct Pulmon Dis; 2016; 11():1269-78. PubMed ID: 27354785
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with exacerbation in mild- to-moderate COPD patients.
Kim JK; Lee SH; Lee BH; Lee CY; Kim do J; Min KH; Kim SK; Yoo KH; Jung KS; Hwang YI
Int J Chron Obstruct Pulmon Dis; 2016; 11():1327-33. PubMed ID: 27366060
[TBL] [Abstract][Full Text] [Related]
3. Different impacts of respiratory symptoms and comorbidities on COPD-specific health-related quality of life by COPD severity.
Lee H; Jhun BW; Cho J; Yoo KH; Lee JH; Kim DK; Lee JD; Jung KS; Lee JY; Park HY
Int J Chron Obstruct Pulmon Dis; 2017; 12():3301-3310. PubMed ID: 29180860
[TBL] [Abstract][Full Text] [Related]
4. The chronic obstructive pulmonary disease assessment test improves the predictive value of previous exacerbations for poor outcomes in COPD.
Miravitlles M; García-Sidro P; Fernández-Nistal A; Buendía MJ; Espinosa de Los Monteros MJ; Esquinas C; Molina J
Int J Chron Obstruct Pulmon Dis; 2015; 10():2571-9. PubMed ID: 26664105
[TBL] [Abstract][Full Text] [Related]
5. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
[TBL] [Abstract][Full Text] [Related]
6. Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD.
Oh YM; Sheen SS; Park JH; Jin UR; Yoo JW; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Lee JS; Lee SD
Int J Tuberc Lung Dis; 2014 Dec; 18(12):1407-14. PubMed ID: 25517804
[TBL] [Abstract][Full Text] [Related]
7. Determining prognosis in acute exacerbation of COPD.
Flattet Y; Garin N; Serratrice J; Perrier A; Stirnemann J; Carballo S
Int J Chron Obstruct Pulmon Dis; 2017; 12():467-475. PubMed ID: 28203070
[TBL] [Abstract][Full Text] [Related]
8. The association of lung function and St. George's respiratory questionnaire with exacerbations in COPD: a systematic literature review and regression analysis.
Martin AL; Marvel J; Fahrbach K; Cadarette SM; Wilcox TK; Donohue JF
Respir Res; 2016 Apr; 17():40. PubMed ID: 27084761
[TBL] [Abstract][Full Text] [Related]
9. Comorbidity as a contributor to frequent severe acute exacerbation in COPD patients.
Jeong SH; Lee H; Carriere KC; Shin SH; Moon SM; Jeong BH; Koh WJ; Park HY
Int J Chron Obstruct Pulmon Dis; 2016; 11():1857-65. PubMed ID: 27536097
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and determinants of COPD exacerbation in the Hokkaido COPD cohort study.
Suzuki M; Makita H; Ito YM; Nagai K; Konno S; Nishimura M;
Eur Respir J; 2014 May; 43(5):1289-97. PubMed ID: 24232696
[TBL] [Abstract][Full Text] [Related]
11. Exacerbations of Chronic Obstructive Pulmonary Disease and Quality of Life of Patients.
Rubinsztajn R; Przybyłowski T; Maskey-Warzechowska M; Karwat K; Chazan R
Adv Exp Med Biol; 2016; 884():69-74. PubMed ID: 26542597
[TBL] [Abstract][Full Text] [Related]
12. Deterioration of quality of life is associated with the exacerbation frequency in individuals with alpha-1-antitrypsin deficiency - analysis from the German Registry.
Bernhard N; Lepper PM; Vogelmeier C; Seibert M; Wagenpfeil S; Bals R; Fähndrich S
Int J Chron Obstruct Pulmon Dis; 2017; 12():1427-1437. PubMed ID: 28553095
[TBL] [Abstract][Full Text] [Related]
13. Impact of Prolonged Exacerbation Recovery in Chronic Obstructive Pulmonary Disease.
Donaldson GC; Law M; Kowlessar B; Singh R; Brill SE; Allinson JP; Wedzicha JA
Am J Respir Crit Care Med; 2015 Oct; 192(8):943-50. PubMed ID: 26151174
[TBL] [Abstract][Full Text] [Related]
14. Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients.
Kawamatawong T; Onnipa J; Suwatanapongched T
Int J Chron Obstruct Pulmon Dis; 2018; 13():761-769. PubMed ID: 29535516
[TBL] [Abstract][Full Text] [Related]
15. 'Exacerbation-free time' to assess the impact of exacerbations in patients with chronic obstructive pulmonary disease (COPD): a prospective observational study.
Boer LM; Bischoff EW; Borgijink X; Vercoulen JH; Akkermans RP; Kerstjens HAM; Assendelft WJ; Schermer TR
NPJ Prim Care Respir Med; 2018 Apr; 28(1):12. PubMed ID: 29615628
[TBL] [Abstract][Full Text] [Related]
16. Exacerbations and health care resource utilization in patients with airflow limitation diseases attending a primary care setting: the PUMA study.
Montes de Oca M; Aguirre C; Lopez Varela MV; Laucho-Contreras ME; Casas A; Surmont F
Int J Chron Obstruct Pulmon Dis; 2016; 11():3059-3067. PubMed ID: 27994446
[TBL] [Abstract][Full Text] [Related]
17. A two-year evaluation of the 'real life' impact of COPD on patients in Germany: The DACCORD observational study.
Kardos P; Vogelmeier C; Worth H; Buhl R; Lossi NS; Mailänder C; Criée CP
Respir Med; 2017 Mar; 124():57-64. PubMed ID: 28284322
[TBL] [Abstract][Full Text] [Related]
18. Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation.
Calverley PM; Page C; Dal Negro RW; Fontana G; Cazzola M; Cicero AF; Pozzi E; Wedzicha JA
Int J Chron Obstruct Pulmon Dis; 2019; 14():2733-2744. PubMed ID: 31819405
[TBL] [Abstract][Full Text] [Related]
19. Exacerbation-related impairment of quality of life and work productivity in severe and very severe chronic obstructive pulmonary disease.
Solem CT; Sun SX; Sudharshan L; Macahilig C; Katyal M; Gao X
Int J Chron Obstruct Pulmon Dis; 2013; 8():641-52. PubMed ID: 24376348
[TBL] [Abstract][Full Text] [Related]
20. Sputum microbiology predicts health status in COPD.
Braeken DC; Houben-Wilke S; Smid DE; Rohde GG; Drijkoningen JJ; Wouters EF; Spruit MA; Franssen FM
Int J Chron Obstruct Pulmon Dis; 2016; 11():2741-2748. PubMed ID: 27853361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]